Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: Results of a large prospective study

Journal of the American Academy of Audiology

Volumn 21, Issue 6, 2010, Pages 409-417

  Dille, Marilyn F ^a   Konrad Martin, Dawn ^a   Gallun, Frederick ^a   Helt, Wendy J ^a   Gordon, Jane S ^a   Reavis, Kelly M ^b   Bratt, Gene W ^c   Fausti, Stephen A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ototoxicity; Ototoxicity monitoring; Tinnitus; Veterans

Indexed keywords

AMIKACIN; AMPICILLIN; CARBOPLATIN; CEFTRIAXONE; CISPLATIN; CLINDAMYCIN; GENTAMICIN; NAFCILLIN; TOBRAMYCIN; VANCOMYCIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT;

ADULT; AGE; AGED; ANALYSIS OF VARIANCE; ANTIBIOTIC THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CHI SQUARE TEST; COMORBIDITY; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HEARING LOSS; HUMAN; INCIDENCE; INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OTOTOXICITY; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TINNITUS; TREATMENT DURATION; VETERAN; BACTERIAL INFECTIONS; CHEMICALLY INDUCED; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; HEARING TEST; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDY; RISK; STATISTICS AND NUMERICAL DATA; TIME; TOXICITY;

ADULT; AGED; AMIKACIN; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BACTERIAL INFECTIONS; CARBOPLATIN; CISPLATIN; CROSS-SECTIONAL STUDIES; FEMALE; GENTAMICINS; HEARING TESTS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; RISK; TIME FACTORS; TINNITUS; TOBRAMYCIN; VANCOMYCIN; VETERANS;

EID: 77956580729     PISSN: 10500545     EISSN: None     Source Type: Journal    
DOI: 10.3766/jaaa.21.6.6     Document Type: Article

References (24)

1. Arora R, Thakur J, Azad R, Mohindroo N, Sharma D, Seam R. (2009) Cisplatin-based chemotherapy: add high-frequency audiometry in the regimen. Indian J Cancer 46(4):311-317.
2. Biro K, Noszek L, Prekopp P, Nagyivanyi K, Geczi L, Gaudi I. (2006) Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emissions. Oncology 70:177-184.
3. Bokemeyer C, Berger CC, Hartmann JT, et al. (1998) Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer. Br J Cancer 77(8):1355-1362.
4. Brummett R. (1980) Drug-induced ototoxicity. Drugs 19(6):412-428.
5. Brummett R, Morrison R. (1990) The incidence of aminoglycoside antibiotic-induced hearing loss. Arch Otolaryngol Head Neck Surg 116:406-410.
6. Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, Ioannidis JPA. (2004) Extended-interval aminoglycoside administration for children: a meta-analysis. Pediatrics 114(1):e111-e118.
7. Davis A, Rafie AE. (2000) Epidemiology of tinnitus. In: Tyler R, ed. Tinnitus Handbook. San Diego: Singular Publishing Group.
8. Dobie RA. (2003) Depression and tinnitus. Otolaryngol Clin North Am 36:383-388.
9. Dobie RA. (2008) The burdens of age-related and occupational noise-induced hearing loss in the United States. Ear Hear 29 (4):565-577.
10. Fausti S, Helt J, Phillips D, et al. (2003b) Early detection of ototoxicity using 1/6th octave steps. J Am Acad Audiol 14(8):444-450.
11. Fausti S, Henry J, Helt W, et al. (1999) An individualized, sensitive frequency range for early detection of ototoxicity. Ear Hear 20 (6):497-505.
12. Fossa S, de Wit R, Roberts J, et al. (2003) Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European organization for research and treatment of cancer genitourinary group/medical research council testicular cancer study group (30941/TE20). J Clin Oncol 21(6):1107-1118.
13. Govaerts P, Claes J, Van De Heyning P, Jorens P, Marquet J, De Broe M. (1990) Aminoglycoside-induced ototoxicity. Toxicol Lett 52:227-251.
14. Hallmark R, Snyder J, Jusenius K, Tamimi H. (1992) Factors influencing ototoxicity in ovarian cancer patients treated with cis-platinum based chemotherapy. Eur J Gynaecol Oncol 13(1):35-44.
15. Kopelman J, Budnick A, Sessions R, Kramer M, Wong G. (1988) Ototoxicity of high-dose cisplatin by bolus administration in patients with advanced cancers and normal hearing. Laryngoscope 98(8):858-864.
16. Lesar TS. (1993) Drug-induced ear and eye toxicity. In: Di Piro JT, Talbert RL, Hayes PE, eds. Pharmacotherapy. 2nd ed. Norwalk: Appleton and Lange, 1349-1362.
17. Mulrow CD, Aguilar C, Endicott J, et al. (1990) Quality of life changes and hearing impairment. A randomized trial. Ann Intern Med 113:188-194.
18. Rizzi M, Hirose K. (2007) Aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg 15:352-357.
19. Rybak L. (2005) Neurochemistry of the peripheral and central auditory system after ototoxic drug exposure: implication for tinnitus. Int Tinnitus J 11(1):23-30.
20. Schmuziger N, Gurtler N, Jungi M, Gratwohl A, Probst R. (2004) Rate of false-positive results for threshold shifts during initial treatment with aminoglycosides. ORL J Otorhinolaryngol Relat Spec 66(3):105-110.
21. Seligmann H, Podoshin L, Ben-David J, Fradis M, Goldsher M. (1996) Drug-induced tinnitus and other hearing disorders. Drug Saf 14(3):198-212.
22. Shotland LI, Ondrey FG, Mayo KA, Viner JL. (2001) Recommendations for cancer prevention trials using potentially ototoxic test agents. J Clin Oncol 19(6):1658-1663.
23. Sindhusake D, Mitchell P, Newall P, Golding M, Rochtchina E, Rubin G. (2003) Prevalence and characteristics of tinnitus in older adults: the Blue Mountain Hearing Study. Int J Audiol 42(5):289-294. (Pubitemid 37372668)
24. Vaughan N, Fausti S, Chelius S, Phillips D, Helt W, Henry J. (2002) An efficient test protocol for identification of a limited, sensitive test range for the early detection of ototoxicity. J Rehabil Res Dev 39:567-574.